Article

Femtosecond laser enables PKP, but not all eyes are candidates

San Francisco-Femtosecond laser-assisted penetrating keratoplasty (PKP) has potential advantages over conventional PKP performed with manual corneal trephination.

San Francisco-Femtosecond laser-assisted penetrating keratoplasty (PKP) has potential advantages over conventional PKP performed with manual corneal trephination. The laser-assisted procedure has disadvantages, however, that should not be overlooked and that make appropriate patient selection, careful preoperative planning, and use of an incomplete incision pattern important, said Anthony Aldave, MD, associate professor of ophthalmology and director, cornea services, Jules Stein Eye Institute, UCLA David Geffen School of Medicine, Los Angeles.

"Femtosecond laser-assisted PKP offers greater wound strength and results in faster visual recovery and less astigmatism than conventional PKP," Dr. Aldave said. "However, the cost of the procedure is higher, there is a risk of wound rupture during patient transport from the refractive suite to the operating room, and there is a higher rate of endothelial cell loss when the donor is cut using the femtosecond laser compared with mechanical trephination."

To illustrate the results of the femtosecond laser-assisted procedure, he reviewed the experience at the Jules Stein Eye Institute, where 18 cases have been performed so far. Endothelial cell density data showed about an 8% loss after donor cutting, whereas about a 3% rate of loss was seen after manual trephination, Dr. Aldave said.

Ten eyes had achieved 3-month follow-up after femtosecond laser-assisted PKP, and refraction data were available for eight of those eyes. In six eyes, astigmatism was 4.5 D or less, and six eyes also experienced best spectacle-corrected visual acuity (BSCVA) of 20/30 or 20/40.

"Comparing groups of eyes that had conventional PKP versus PKP using a femtosecond laser-assisted, zig-zag technique, Roger Steinert, MD, found the femtosecond laser group had less astigmatism at all follow-up intervals from 1 to 12 months as well as an advantage for better BSCVA at 1 and 3 months, with no significant difference between groups thereafter," Dr. Aldave said.

Candidates for the femtosecond laser-assisted procedure are patients with stromal opacification or ectasia without comorbid ocular pathology, he said. Patients are considered marginal candidates if they have moderately dense midperipheral corneal opacity, a failed corneal transplant, or any factors that may predispose to suction loss during the femtosecond laser procedure, he added.

Eyes with a dense midperipheral corneal opacity, very thick (>1200 µm) or very thin (

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.